(Q50422607)
Statements
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma (English)
1 February 2018
1 reference
ImageQuant
ImageQuant TL
2 references
scientific article published on 14 February 2018